Original Report

A weekly speech and language therapy service for head and neck radiotherapy patients during treatment: maximizing accessibility and efficiency


 

Background Our hospital did not provide a weekly speech and language therapy (SLT) service for head and neck cancer patients during radiotherapy treatment. SLT is recommended in the international guidelines, but many centers do not offer this service. In the case of our hospital, SLT was not provided because there were no funds to cover the costs of additional staff.

Objectives To create a new service model within a multidisciplinary setting to comply with the international SLT guidelines and without increasing staff. We aimed to measure the accessibility and efficiency of a new model of service delivery at our center both for patients and for the service.

Methods 79 patients were recruited for the study. We followed 1 group of patients (n = 29; observation group) throughout their treatment for 6 weeks to establish if there was a clinical need to offer SLT at the treatment center. A second group of patients (n = 50; intervention group) received a weekly SLT review at the treatment center throughout their radiotherapy. Data collected at the tertiary cancer center for 6 months included: age, gender, tumor site and size, treatment modality, swallowing outcomes, communication outcomes, patient satisfaction, multidisciplinary team feedback, and time efficiency. The observation group did not participate in the intervention group because the data was collected between 2 different groups of participants. However, all participants were referred to their local SLT service at the end of their treatment if that was clinically indicated, regardless of the group they had been in.

Results The proportion of patients accessing SLT services during treatment and the time efficiency of the service were both improved with this model of delivery. The service’s compliance with international guidelines was met. More patients continued with oral intake during their treatment at our center with the new service. Improvements were also reported in communication clarity and communication confidence in the same group.

Conclusion Offering head and neck cancer patients SLT at the same time and place as their radiotherapy treatment improves patient outcomes and increases SLT efficiencies. As this was not a treatment study, further clinical trials are required with regards to functional outcomes.

Click on the PDF icon at the top of this introduction to read the full article.

Recommended Reading

VIDEO: Elective neck dissection during primary surgery improves oral cancer survival
MDedge Hematology and Oncology
AACE: How to safely skip radioactive iodine for low-grade thyroid cancer
MDedge Hematology and Oncology
ASA: Mutation testing aids decision making in thyroid cancer
MDedge Hematology and Oncology
Thyroid cancer outcomes worse for black and Hispanic young adults
MDedge Hematology and Oncology
Thyroid cancer gene screening questioned for indeterminate nodules
MDedge Hematology and Oncology
RAI given to thyroid CA patients does not increase their breast malignancy occurrence, recurrence
MDedge Hematology and Oncology
Gene-testing predictive value can depend on institutional cancer prevalence
MDedge Hematology and Oncology
New guidelines focus on pediatric thyroid nodules and cancer
MDedge Hematology and Oncology
Moderate THST was most effective at treating thyroid cancer
MDedge Hematology and Oncology
ASCO 2015: from data and learning, to daily practice
MDedge Hematology and Oncology